Cytogenetic analysis and fluorescence in situ hybridization in a case of IgD multiple myeloma

Cancer Genetics and Cytogenetics

Volumn 105, Issue 2, 1998, Pages 172-176

  Weinländer, Georg ^a   Drach, Johannes ^a   Raderer, Markus ^a   Okamoto, Ichiro ^a   Ackermann, Jutta ^a   Stögermayer, Barbara ^a   Fazeny, Barbara ^a   Nowotny, Hadwiga ^a   Marosi, Christine ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; DEXAMETHASONE; DOXORUBICIN; IMMUNOGLOBULIN D; MELPHALAN; PARAPROTEIN; PREDNISOLONE; URIC ACID; VINCRISTINE;

AGED; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME LOSS; CHROMOSOME TRANSLOCATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IMMUNOELECTROPHORESIS; KARYOTYPE; MONOSOMY; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROGNOSIS; X CHROMOSOME ABERRATION;

AGED; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 7; FEMALE; HUMANS; IMMUNOGLOBULIN D; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MULTIPLE MYELOMA;

EID: 0032171666     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00025-9     Document Type: Article

References (19)

1. Bladé J., Lust J.A., Kyle R.A. Immunoglobulin D multiple myeloma. presenting features, response to therapy and survival in a series of 53 cases J Clin Oncol. 12:1994;2398-2404.
2. Rowe D.S., Fahey J.L. A new class of human immunoglobulins. a unique myeloma protein J Exp Med. 121:1965;171-184.
3. Johnston J.B., Weinerman B., Cooney T. IgD kappa plasma cell dyscrasias. extraosseous manifestations including isolated leptomeningitis Am J Clin Pathol. 77:1982;60-65.
4. Jancelewicz Z., Takatsuki K., Sugai S. IgD multiple myeloma. review of 133 cases Arch Intern Med. 135:1975;87-93.
5. Drach J., Schuster J., Nowotny H., Angeler J., Rosenthal F., Fiegl M., Rothermundt C., Gsur A., Jäger U., Heinz R., Lechner K., Ludwig H., Huber H. Multiple myeloma. high incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization Cancer Res. 55:1995;3854-3859.
6. Latreille J., Barlogie B., Gohde W., Johnston D., Drewinko B., Alexanian R. Cellular DNA content as a marker of human multiple myeloma. Blood. 55:1980;403-410.
7. Tricot G., Barlogie B., Jagannath S., Bracy D., Mattox S., Vesole D.H., Naucke S., Sawyer J.R. Poor prognosis in multiple myeloma is associated only with partial deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities. Blood. 86:1995;4250-4256.
8. Weh H.J., Gutensohn K., Selbach J., Kruse R., Wacker-Backhaus G., Seeger D., Fiedler W., Fett W., Hossfeld D.K. Karyotype in multiple myeloma and plasma cell leukemia. Eur J Cancer. 29A:1993;1269-1273.
9. Lai J.L., Zandecki M., Mary J.Y., Bernardi F., Izdorczyk V., Flactif M., Moret P., Jouet J.P., Bauters F., Facon T. Improved cytogenetics in multiple myeloma. a study of 151 patients including 117 patients at diagnosis Blood. 85:1995;2490-2497.
10. Lewis J.P., MacKenzie M.R. Non-random chromosomal aberrations associated with multiple myeloma. Hematol Oncol. 4:1984;307-317.
11. Gould J., Alexanian R., Goodacre A., Pathak S., Hecht B., Barlogie B. Plasma cell karyotype in multiple myeloma. Blood. 71:1988;453-456.
12. Flactif M., Lai J.L., Zandecki M., Bernardi F., Trillot N., Bauters F., Facon T. Two cases of translocation t(1;16) (p11;p11) in multiple myeloma. confirmation by chromosome painting Cancer Genet Cytogenet. 76:1994;10-14.
13. Flactif M., Zandecki M., Lai J.L., Bernardi F., Obein V., Bauters F., Facon T. Interphase fluorescence in situ hybridization (FISH) as a powerful tool for the detection of aneuploidy in multiple myeloma. Leukemia. 9:1995;2109-2114.
14. Delannoy A., Hamels J., Mecucci C., Fally P., Wallef G., De Fooz C., Carlier B. Amylase producing IgD-type myeloma. J Int Med. 232:1992;457-460.
15. Ishii K., Yamato K., Kubonishi I., Tagushi H., Ohtsuki Y., Mi-yoshi I. IgD myeloma presenting as a testicular tumor. establishment and characterization of an IgD-secreting myeloma cell line Am J Hematol. 41:1992;218-224.
16. Pirc-Danoewinata H., Chott A., Onderka E., Drach J., Schlögl E., Jäger U., Thalhammer F., Nowotny H., Aryee D., Steger G.G., Locker G., Michl I., Djavanmard M., Simonitsch I., Radaskiewicz T., Hanak H., Schneider B., Heinz R., Marosi C. Karyotype and prognosis in non-Hodgkin lymphoma. Leukemia. 8:1994;1929-1939.
17. Schweizer D. Simultaneous fluorescent staining of R bands and specific heterochromatic regions (DA-DAPI bands) in human chromosomes. Cytogenet Cell Genet. 27:1980;190-197.
18. ISCN (1995): An International System for Human Cytogenetic Nomenclature. F Mitelman, ed. S. Karger, Basel.
19. Dewald G.W., Kyle R.A., Hicks G.A., Greipp P.R. The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia or amyloidosis. Blood. 66:1985;380-390.